Marek Babjuk
Impact in
Papers in
- Co-authors
- Shahrokh F. ShariatPierre I. KarakiewiczPaolo GonteroYair LotanHugh MostafidL. JarolímRichard SylvesterJeremy Yuen‐Chun Teoh
- Journals
- European Urology (9 papers)Urologic Oncology Seminars and Original Investigations (6 papers)Journal of Clinical Oncology (4 papers)European Urology Focus (3 papers)Current Opinion in Urology (3 papers)
- Partner nations
- CzechiaUnited StatesAustria
In The Last Decade
Marek Babjuk
77 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Urology 541
- Surgery 1.6k
- Oncology 478
- Cancer Research 210
- Pulmonary and Respiratory Medicine 378
Countries citing papers authored by Marek Babjuk
This map shows the geographic impact of Marek Babjuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Babjuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Babjuk more than expected).
Fields of papers citing papers by Marek Babjuk
This network shows the impact of papers produced by Marek Babjuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Babjuk. The network helps show where Marek Babjuk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marek Babjuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 19 | |
| 6 | 2020 | 0 | |
| 7 | Prevence recidivujících cystitid pomocí roztoku hyaluronátu sodného Flaveran | 2020 | 2 |
| 8 | 2019 | 0 | |
| 9 | 2018 | 0 | |
| 10 | Porovnání detekce signifikantního a nesignifikantního karcinomu pomocí systematické a cílené fúzní MRI/TRUS biopsie prostaty | 2018 | 0 |
| 11 | 2016 | 48 | |
| 12 | 2013 | 0 | |
| 13 | 2013 | 130 | |
| 14 | Časná salvage radioterapie po radikální prostatektomii indikovaná u pacientů s rostoucí hladinou PSA v hodnotách nižších, než je konvenční hranice biochemické recidivy 0,2 ng/ml | 2012 | 0 |
| 15 | 2009 | 2 | |
| 16 | Predikce patologické klasifikace karcinomu prostaty | 2008 | 0 |
| 17 | Nádory močového měchýře | 2005 | 1 |
| 18 | Intravezikální léčba povrchových nádorů močového měchýře | 2005 | 0 |
| 19 | 2000 | 6 | |
| 20 | Anatomický podklad a klinická interpretace ortotopické neoveziky u ženy | 1998 | 1 |
About Marek Babjuk
Marek Babjuk is a scholar working on Urology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 93 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (60 papers), Urinary and Genital Oncology Studies (42 papers), Urological Disorders and Treatments (22 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (10 papers), Renal cell carcinoma treatment (8 papers), Colorectal Cancer Screening and Detection (8 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Urology (541 citations), Surgery (1.6k citations), Oncology (478 citations), Cancer Research (210 citations) and Pulmonary and Respiratory Medicine (378 citations). Marek Babjuk has collaborated with scholars based in Czechia, United States and Austria. Frequent co-authors include Shahrokh F. Shariat, Pierre I. Karakiewicz, Paolo Gontero, Yair Lotan, Hugh Mostafid, L. Jarolím, Richard Sylvester, Jeremy Yuen‐Chun Teoh, Ashish M. Kamat and Peter C. Black. Their work appears in journals such as European Urology, Urologic Oncology Seminars and Original Investigations, Journal of Clinical Oncology, European Urology Focus and Current Opinion in Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.